Leadership

Our proven executive team brings deep, diverse cell therapy experience and is committed to developing safe, effective, and accessible NK cell therapies to patients. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Executives Directors Advisors

Fred Aslan, M.D.

President and Chief Executive Officer

View Bio »

Jennifer Bush

EVP, Chief Legal & People Officer

View Bio »

Peter Flynn, Ph.D.

Cofounder, Strategic Advisor

View Bio »

Thorsten Graef, M.D., Ph.D.

Chief Medical Officer

View Bio »

Christopher Horan

Chief Technical Operations Officer

View Bio »

Eugene Helsel

Vice President, Regulatory Affairs & Quality

View Bio »

John Lim, Pharm.D.

Vice President, Clinical Operations

View Bio »

Heather Raymon, Ph.D.

SVP, Research & Early Development

View Bio »